Biotechnology News

November 7, 2012

NEW YORK--(BUSINESS WIRE)--Hessen will participate in the MEDICA 2012, November 14-17, 2012 in Düsseldorf. Hessen utilizes the appeal of MEDICA to present the quality of its business location and international medtech industry

November 7, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that Klaus Lindpaintner, MD, MPH, and Edison T. Liu, MD, have joined its Scientific Advisory Board. The board was...

November 7, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, today announced that Sanj K. Patel, President and Chief...

November 7, 2012

FREMONT, Calif.--(BUSINESS WIRE)--DiscoveRx today announced the acquisition of BioSeek, a drug discovery services company based in South San Francisco, California. BioSeek’s phenotypic screening technology improves the success rate of...

November 7, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that Frank Thomas, AMAG’s Chief Operating Officer, will present a company overview and business update at the Lazard Capital Markets 9th Annual Healthcare...

November 7, 2012

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Foundation, Asian-Pacific community groups share learnings on viral hepatitis management at Delivering Hope conference.

November 7, 2012

WILMINGTON, Del. & COLD SPRING HARBOR, N.Y.--(BUSINESS WIRE)--DuPont and CSHL have renewed for another 5 years of a research collaboration that began in 2007 and supports cutting-edge plant biology research focused on meeting growing food...

November 7, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--A recent Cutting Edge Information study finds that digital and mobile centers of excellence enable the development of value-based initiatives that enhance the lives of target audiences.

November 7, 2012

ALAMEDA, Calif. & JERUSALEM--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) and its subsidiary Cell Cure Neurosciences Ltd. (Cell Cure) today announced that they have entered into a share purchase agreement through which BioTime agreed to...

November 7, 2012

LOS ANGELES--(BUSINESS WIRE)--CEO and President Alan Auerbach will provide an update on cancer drug development at Puma Biotechnology on November 14 at the Lazard 9th Annual Healthcare Conference.

November 7, 2012

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Medical Imaging, Inc. (“Lantheus”) today announced that it will host a conference call at 4:00 p.m. ET on Tuesday, November 13, 2012 to discuss its financial and operating results for the third...

November 7, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE MKT: SNT) reported today that the clinical trial of SNS01-T has been expanded to include diffuse large B-cell lymphoma (DLBCL) and mantle cell...

November 7, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA) announced today that interim results from the Phase 2b/3 GALAXY trial will be presented at the Chemotherapy Foundation Symposium in New York City on Friday, November 9...

November 7, 2012

ALACHUA, Fla.--(BUSINESS WIRE)--AxoGen, Inc. (OTCBB: AXGN), a leading regenerative medicine company dedicated to advancing the science and commercialization of peripheral nerve repair solutions, today announced revenues for the third quarter...

November 7, 2012

MORRISVILLE, N.C.--(BUSINESS WIRE)--Shinagawa LASIK Center, the largest LASIK center in Japan, has acquired TearScience's system to better serve its patients who suffer from evaporative dry eye.

November 7, 2012

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) today announced its presentations at two upcoming investor conferences will be webcast live and will be available in the investor relations section of the company’s web site at...

November 7, 2012

WOBURN, Mass.--(BUSINESS WIRE)--ArQule announces upcoming presentation at Lazard Healthcare Conference on November 14, 2012.

November 7, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today reported financial results for the third quarter and nine months ended September 30, 2012 and provided an update on corporate developments. “We are advancing the...

November 7, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Repligen Corporation (NASDAQ:RGEN) today announced that Walter C. Herlihy, Ph.D., President and Chief Executive Officer, will be presenting at two investor conferences in November. Dr. Herlihy will first...

November 7, 2012

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (NASDAQ: BRKR) announced today that it will present at the Lazard Capital Markets 9th Annual Healthcare Conference on Wednesday, November 14, 2012, at 10:00 AM Eastern Standard Time in New...

November 7, 2012

JERUSALEM--(BUSINESS WIRE)--BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, announced today that in vivo and in vitro data demonstrating the efficacy of BL-8040 in treating chronic myeloid leukemia (CML) has...

November 7, 2012

SAN CARLOS, Calif.--(BUSINESS WIRE)--Natus Medical Incorporated (Nasdaq:BABY) today announced financial results for the three and nine months ended September 30, 2012. For the third quarter ended September 30, 2012, the Company reported revenue...

November 7, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) announced today that executive management will participate in two upcoming conferences. Gustav Christensen, President and Chief Executive Officer of Dyax, will present on Wednesday,...

November 7, 2012

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today reported financial and operating results for the third quarter ended September 30, 2012. Quarter and Recent Highlights Completed all clinical studies for the VIBEX™ MTX Medi-...

November 7, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE: EBS) announced today that an abstract on its bispecific protein therapeutic targeting prostate cancer has been accepted for presentation at the 24th Annual EORTC-NCI-AACR...

November 7, 2012

MANSFIELD, Mass.--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, will present at the Jefferies 2012 Global Healthcare Conference in London on November 14, 2012. Coleman N. Lannum, Vice President, Investor...

November 7, 2012

BETHESDA, Md.--(BUSINESS WIRE)--Sucampo's presentation from the 2012 Credit Suisse Healthcare Conference will be webcast on Wed., Nov. 14, at 11:30 am Mountain, or 1:30 pm Eastern.

November 7, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that Caris Life Sciences has selected its MiSeq sequencing system to support Caris’ evidence-based molecular profiling service. The MiSeq system will be deployed to enable ...

November 7, 2012

CAMBRIDGE, Mass. & DUBLIN--(BUSINESS WIRE)--Aileron Therapeutics Presents New Data on Stapled Peptide Oncology Program at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

November 7, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC: n3D Technology Advances Cell Research

November 7, 2012

CHALFONT ST. GILES, England--(BUSINESS WIRE)--GE Healthcare today announced results of three health economic models to estimate the potential cost offsets to the healthcare system of biomarker testing in patients with early breast cancer,...

November 7, 2012

MEQUON, Wis.--(BUSINESS WIRE)--Titan Spine announces the hiring of Marcus Klarl as the Vice President of Sales for Europe.

November 7, 2012

SAN DIEGO & LEIDEN, Netherlands--(BUSINESS WIRE)--Santarus, Inc. and Pharming Group NV announced that the Phase 3 clinical study to evaluate RUCONEST for the treatment of acute attacks of angioedema in patients with HAE met the primary...

November 6, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--LipoScience, Inc. today presented key findings related to lipoprotein particles (LDL-P) and cardiovascular disease at the Annual Meeting of the American Heart Association (AHA) in Los Angeles.

November 6, 2012

CHAPEL HILL, N.C.--(BUSINESS WIRE)--POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to transforming medicine that transforms lives, presented positive results from two pivotal Phase 3 clinical trials of the investigational product,...

November 6, 2012

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) has received approval from the U.S. Food and Drug Administration (FDA) for XELJANZ® (tofacitinib citrate) 5 mg twice daily for the treatment of adults with moderately to severely active...

November 6, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's Biologics License Application (BLA) for...

November 6, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced that Genentech, a member...

November 6, 2012

SAN MATEO, Calif.--(BUSINESS WIRE)--Maxygen, Inc. (Nasdaq:MAXY), a biotechnology company, today announced financial and business results for the quarter ended September 30, 2012. Third Quarter 2012 Financial Results Maxygen reported a net loss...

November 6, 2012

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today reported its financial results for the third quarter and nine months ended September 30,...

November 6, 2012

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics today announced results for its fourth quarter and fiscal year ended September 30, 2012.

November 6, 2012

PLEASANTON, Calif.--(BUSINESS WIRE)--IntegenX has introduced directional messenger RNA (mRNA) kit for automated next generation sequencing (NGS) library preparation on the Apollo 324™ System.

November 6, 2012

PARSIPPANY, N.J.--(BUSINESS WIRE)--IMS Health plans to post for note holders its third-quarter 2012 financial results on Monday, November 12, 2012. The company will conduct a conference call for IMS’s note holders to review these results at 1:00...

November 6, 2012

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) announced today that it will issue its third quarter 2012 financial release on Friday, November 9, 2012 at approximately 8:00 a.m. ET. The press release will be followed...

November 6, 2012

SAN CARLOS, Calif.--(BUSINESS WIRE)--BioCardia, Inc. announced positive results from a Phase 1/2 heart failure trial where allogeneic and autologous mesenchymal (adult) stem cells (MSCs) were delivered via transendocardial injection.

November 6, 2012

BEND, Ore.--(BUSINESS WIRE)--Announcing the expansion of BiomarkerBase™ to include biomarkers in clinical trials. The expansion also includes lists of every FDA-approved IVD test for each biomarker in the database.

November 6, 2012

NEW YORK--(BUSINESS WIRE)--6th Annual ‘OneMedForum’ Announces Special Programming

November 6, 2012

SAN DIEGO--(BUSINESS WIRE)--BioSurplus announced today that it will be hosting a major lab equipment surplus liquidation auction for Geron, ACADIA Pharmaceuticals and a confidential San Diego biotech company.

November 6, 2012

FAIRFAX, Va.--(BUSINESS WIRE)--Cancer patients can now receive fully integrated care with medical oncologists and radiation oncologists working together as a team at Virginia Cancer Specialists